Stock 3341 NIHON CHOUZAI CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings NIHON CHOUZAI Co.,Ltd.

Equities

3341

JP3729200000

Market Closed - Japan Exchange
Other stock markets
 11:30:00 02/05/2024 am IST 		5-day change 1st Jan Change
1,368 JPY +0.66% Intraday chart for NIHON CHOUZAI Co.,Ltd. -7.69% -2.22%
02/05 Japanese Shares Muted Amid Firm Yen, Mixed Wall Street MT
02/05 Nihon Chouzai's Fiscal 2024 Attributable Profit Misses Forecast on Extraordinary Losses MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Its low valuation, with P/E ratio at 9.13 and 8.34 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The stock, which is currently worth 2024 to 0.21 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
NIHON CHOUZAI CO.,LTD. Stock NIHON CHOUZAI Co.,Ltd.
-2.22% 268M -
RAIA DROGASIL S.A. Stock Raia Drogasil S.A.
-10.75% 8.88B
B
AIN HOLDINGS INC. Stock Ain Holdings Inc.
+39.05% 1.43B -
QOL HOLDINGS CO., LTD. Stock Qol Holdings Co., Ltd.
+8.27% 438M -
SALUS, LJUBLJANA, D. D. Stock SALUS, Ljubljana, d. d.
+10.56% 226M - -
GREEN CROSS HEALTH LIMITED Stock Green Cross Health Limited
-8.26% 86.33M - -
PETMED EXPRESS, INC. Stock PetMed Express, Inc.
-46.43% 82.6M
C
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 3341 Stock
  4. Ratings NIHON CHOUZAI Co.,Ltd.